|Bid||0.0000 x 0|
|Ask||0.0000 x 0|
|Day's Range||0.0000 - 0.0000|
|52 Week Range|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
Yahoo Finance's LIVE market coverage and analysis of what you need to watch in the stock market begins each day at 9:25 a.m. ET.
BRUSSELS, Nov 3 (Reuters) - The following are mergers under review by the European Commission and a brief guide to the EU merger process: APPROVALS AND WITHDRAWALS -- France's CNP Assurances, Australian ...
Trump has decried these price hikes since the campaign. President Donald Trump blasted Merck CEO Kenneth C. Frazier on Monday morning after Frazier announced he was leaving the President’s manufacturing council following Trump’s equivocal response to the neo-Nazi and white nationalist rally in Charlottesville, Virginia. In March, Democratic Representatives Elijah Cummings (MD) and Peter Welch (VT) met with Trump to discuss their bill that would help lower prescription drug prices by allowing regulated drug importation and Medicare’s ability to negotiate wholesale prices for wholesale drugs, instead of retail prices.
May.03 -- Werner Baumann, chief executive officer at Bayer, discusses earnings, a pending deal with Monsanto and the overall outlook for the company. He speaks with Matt Miller and Guy Johnson on “Bloomberg Markets: European Open.”
Mar.21 -- Bloomberg's Aoife White discusses Bayer's pledge to sell BASF seeds, pesticides and digital agriculture technology as a bargaining chip to buy Monsanto. She speaks on "Bloomberg Markets: European Close."
Mar.15 -- Bloomberg's Ed Hammond discusses Bayer's plan to takeover Monsanto. Two people familiar with the matter say U.S. antitrust officials are worried the merger could hurt competition. Hammond speaks with Vonnie Quinn and Mark Barton on "Bloomberg Markets: European Close."
Feb.28 -- Bayer says it may sell more businesses in addition to its seeds unit as its existing units struggle and the process of closing its $66 billion acquisition of Monsanto drags on. Bayer Chief Executive Officer Werner Baumann discusses potential divestitures with Bloomberg's Francine Lacqua and Tom Keene on "Bloomberg Surveillance."
Oct.26 -- Bayer AG is teaming up with Ginkgo Bioworks, a Boston-based biotechnology company, on a record $100-million wager on farming technology. The seeds for bets like these are sewn at the Bayer Lifescience Center in Cambridge, Massachusetts. Bloomberg's Anne Mostue reports.
Oct.13 -- BASF has agreed to buy part of Bayer's seed and herbicide business for $7B, helping to clear the way for Bayer's $66B acquisition of Monsanto. Bloomberg's Phil Serafino reports on "Bloomberg Daybreak: Europe."